Investors
Information Disclosure
-
VOLUNTARY ANNOUNCEMENT - APPROVAL FOR MARKETING OF "LIRAGLUTIDE INJECTION"2024.06.25
-
VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES BY CHIA TAI TIANQING UNDER THE SHARE INCENTIVE SCHEME2024.06.20
-
VOLUNTARY ANNOUNCEMENT - COMPLETION OF ISSUANCE OF FIRST TRANCHE OF PANDA BONDS2024.06.20
-
VOLUNTARY ANNOUNCEMENT - APPROVAL FOR MARKETING OF CATEGORY 1 INNOVATIVE DRUG ENVONALKIB CITRATE CAPSULES "ENVONALKIB (TQ-B3139)"2024.06.19
-
VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES BY CHIA TAI TIANQING UNDER THE SHARE INCENTIVE SCHEME2024.06.13
-
VOLUNTARY ANNOUNCEMENT - APPROVAL FOR MARKETING OF "GADOTERIDOL INJECTION"2024.06.12
-
VOLUNTARY ANNOUNCEMENT - KRAS G12C INHIBITOR "GARSORASIB TABLET (D-1553)" INCLUDED IN THE BREAKTHROUGH THERAPEUTIC DESIGNATION PROCESS2024.06.11
-
VOLUNTARY ANNOUNCEMENT - PUBLICATION OF STUDY FINDINGS OF PHASE II CLINICAL TRIAL OF KRAS G12C INHIBITOR "GARSORASIB TABLET (D-1553)" IN THE LANCET RESPIRATORY MEDICINE2024.06.11